KLF4 inhibition by Kenpaullone induces cytotoxicity and chemo sensitization in B-NHL cell lines via YY1 independent

References

• Jaffe ES, Harris NL, Stein H, et al. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood. 2008;112(12):4384–4399.
   PubMed Web of Science ®Google Scholar
• Percy C, O'conor G, Ries LG, et al. Non-Hodgkin’s lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the working formulation. Cancer. 1984;54(7):1435–1438.
   PubMed Web of Science ®Google Scholar
• Mueller N, Mohar A, Evans A, et al. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer. 1991;49(3):387–393.
   PubMed Web of Science ®Google Scholar
• Ghaleb AM, Yang VW. Krüppel-like factor 4 (KLF4): what we currently know. Gene. 2017;611:27–37.
   PubMed Web of Science ®Google Scholar
• Evans PM, Liu C. Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai). 2008;40(7):554–564.
   PubMed Web of Science ®Google Scholar
• Valencia-Hipólito A, Hernández-Atenógenes M, Vega GG, et al. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma. Leuk Lymphoma. 2014;55(8):1806–1814.
   PubMed Web of Science ®Google Scholar
• Morales-Martinez M, Valencia-Hipolito A, Vega GG, et al. Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma. Oncotarget. 2019;10(22):2173–2188.
   PubMedGoogle Scholar
• Shin SH, Kwon YW, Heo SC, et al. Krüppel-like factor 4 mediates lysophosphatidic acid-stimulated migration and proliferation of PC3M prostate cancer cells. Exp Mol Med. 2014;46(7):e104.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983–3988.
   PubMed Web of Science ®Google Scholar
• Schultz C, Link A, Leost M, et al. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. J Med Chem. 1999;42(15):2909–2919.
   PubMed Web of Science ®Google Scholar
• Yu F, Shi Y, Wang J, et al. Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells. Int J Cancer. 2013;133(12):2872–2883.
   PubMed Web of Science ®Google Scholar
• Tien Y-T, Chang M-H, Chu P-Y, et al. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells. Vet J. 2015;205(2):244–253.
   PubMed Web of Science ®Google Scholar
• Kitabayashi T, et al. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma. DOI:https://doi.org/10.1038/s41598-019-46454-8
   Google Scholar
• Lyssiotis C, Foreman R. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U S A. 2009;106(22):8912–8917.
   PubMed Web of Science ®Google Scholar
• Huang R-Y, Pei L, Liu QJin, et al. Isobologram analysis: A comprehensive review of methodology and current research. Front Pharmacol. 2019;10:1222.
   PubMed Web of Science ®Google Scholar
• Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis. 1978;137(2):122–130.
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson KSJ, Jenson SD, Abbott RT, et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci U S A. 2003;100(12):7259–7264.
   PubMed Web of Science ®Google Scholar
• Klapper W, Szczepanowski M, Burkhardt B, Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe, et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood. 2008;112(4):1374–1381.
   PubMed Web of Science ®Google Scholar
• Tai S-K, Yang M-H, Chang S-Y, et al. Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer Sci. 2011;102(4):895–902.
   PubMed Web of Science ®Google Scholar
• Pandya AY, Talley LI, Frost AR, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res. 2004;10(8):2709–2719. [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/15102675.
   PubMed Web of Science ®Google Scholar
• Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer. 2006;6(1):11–23.
   PubMed Web of Science ®Google Scholar
• Yu F, Li J, Chen H, et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene. 2011;30(18):2161–2172.
   PubMed Web of Science ®Google Scholar
• Huang CC, Liu Z, Li X, et al. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol Ther. 2005;4(12):1401–1408.
   PubMed Web of Science ®Google Scholar
• Foster KW, Ren S, Louro ID, et al. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 1999;10(6):423–434.
   PubMedGoogle Scholar
• Guan H, Xie L, Leithäuser F, et al. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood. 2010;116(9):1469–1478.
   PubMed Web of Science ®Google Scholar
• Yoon O, Roh J. Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer. Oncol Lett. 2012;4(5):1033–1036.
   PubMed Web of Science ®Google Scholar
• Kim EM, Jung CH, Kim J, et al. The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins. Cancer Res. 2017;77(11):3092–3100.
   PubMed Web of Science ®Google Scholar
• Dang DT, Zhao W, Mahatan CS, et al. Opposing effects of Krüppel-like factor 4 (gut-enriched Krüppel-like factor) and Krüppel-like factor 5 (intestinal-enriched Krüppel-like factor) on the promoter of the Krüppel-like factor 4 gene. Nucleic Acids Res. 2002;30(13):2736–2741.
   PubMed Web of Science ®Google Scholar
• Yusuf I, Kharas MG, Chen J, et al. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int Immunol. 2008;20(5):671–681.
   PubMed Web of Science ®Google Scholar
• Chen M, Ye A, Wei J, et al. Deoxycholic acid upregulates the reprogramming factors KFL4 and OCT4 through the IL-6/STAT3 pathway in esophageal adenocarcinoma cells. Technol Cancer Res Treat. 2020;19:1–17.
   Web of Science ®Google Scholar
• Choi H, Roh J. LH-induced transcriptional regulation of KLF4 expression in granulosa cells occurs via the camp/pka pathway and requires a putative sp1 binding site. Int J Mol Sci. 2020;21(19):1–14.
   Web of Science ®Google Scholar
• Chen ZY, Rex S, Tseng CC. Krüppel-like factor 4 is transactivated by butyrate in colon cancer cells. J Nutr. 2004;134(4):792–798.
   PubMed Web of Science ®Google Scholar
• Deaton RA, Gan Q, Owens GK. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol. 2009;296(4):H1027–H1037.
   PubMed Web of Science ®Google Scholar
• Lin C-C, Liu L-Z, Addison JB, et al. A KLF4-miRNA-206 Autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context. Mol Cell Biol. 2011;31(12):2513–2527.
   PubMed Web of Science ®Google Scholar
• Hujie G, Zhou S-H, Zhang H, et al. MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma. Cancer Cell Int. 2018;18(1):10.
   PubMed Web of Science ®Google Scholar
• Miao X, Wu X, Shi W. MicroRNA-346 regulates neural stem cell proliferation and differentiation by targeting KLF4. Am J Transl Res. 2017;9(12):5400–5410.
   PubMed Web of Science ®Google Scholar
• Morales-Martinez M, Vega GG, Neri N, et al. MicroRNA-7 regulates migration and chemoresistance in non-hodgkin lymphoma cells through regulation of KLF4 and YY1. Front Oncol. 2020;10:588893.
   PubMed Web of Science ®Google Scholar
• Suske G, Bruford E, Philipsen S. Mammalian SP/KLF transcription factors: bring in the family. Genomics. 2005;85(5):551–556.
   PubMed Web of Science ®Google Scholar
• Vega MI, Huerta-Yepaz S, Garban H, et al. Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Oncogene. 2004;23(20):3530–3540.
   PubMed Web of Science ®Google Scholar
• Tsang WP, Zhang F, He Q, et al. Icaritin enhances mESC self-renewal through upregulating core pluripotency transcription factors mediated by ERα. Sci Rep. 2017;7:40894.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang Q, Yin X, et al. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res. 2011;21(1):196–204.
   PubMed Web of Science ®Google Scholar